Research

Our research focuses on developing new approaches to prevent and treat infectious diseases, chronic inflammation, and cancer.
 

I3V Research impact

Infectious diseases remain major causes of preventable mortality and morbidity worldwide. New vaccines and mechanisms to ensure their appropriate and cost-effective use are required to meet these challenges.

Chronic inflammatory diseases are a particular burden in aging populations. Rheumatoid arthritis, multiple sclerosis and Inflammatory Bowel Diseases are particularly prevalent in the Maritime Provinces for reasons which are poorly understood.

New immune-based therapies for cancer are already having some impact, even in metastatic disease, and highlight the tremendous opportunities for harnessing manipulation of immune responses and viroceutical therapies to combat such disease.

With Nova Scotia having the highest per capita cancer incidence in the country, with increased global concern for viral pandemics and emerging viral diseases, and with an interest in expanding research activity in the regional biotechnology sector, our objectives clearly align with Nova Scotia’s research and economic development priorities.

The impact of I3V research can be measured in a variety of ways both locally and globally, including:

• New licenced treatments
• Clinical trials
• Patents and intellectual property
• Peer-reviewed publications and citations
• Training of the next generation of researchers and clinicians
• Informing and engaging community and stakeholders